Wani, T.A.; Alanazi, M.M.; Alsaif, N.A.; Bakheit, A.H.; Zargar, S.; Alsalami, O.M.; Khan, A.A.
Interaction Characterization of a Tyrosine Kinase Inhibitor Erlotinib with a Model Transport Protein in the Presence of Quercetin: A Drug–Protein and Drug–Drug Interaction Investigation Using Multi-Spectroscopic and Computational Approaches. Molecules 2022, 27, 1265.
https://doi.org/10.3390/molecules27041265
AMA Style
Wani TA, Alanazi MM, Alsaif NA, Bakheit AH, Zargar S, Alsalami OM, Khan AA.
Interaction Characterization of a Tyrosine Kinase Inhibitor Erlotinib with a Model Transport Protein in the Presence of Quercetin: A Drug–Protein and Drug–Drug Interaction Investigation Using Multi-Spectroscopic and Computational Approaches. Molecules. 2022; 27(4):1265.
https://doi.org/10.3390/molecules27041265
Chicago/Turabian Style
Wani, Tanveer A., Mohammed M. Alanazi, Nawaf A. Alsaif, Ahmed H. Bakheit, Seema Zargar, Ommalhasan Mohammed Alsalami, and Azmat Ali Khan.
2022. "Interaction Characterization of a Tyrosine Kinase Inhibitor Erlotinib with a Model Transport Protein in the Presence of Quercetin: A Drug–Protein and Drug–Drug Interaction Investigation Using Multi-Spectroscopic and Computational Approaches" Molecules 27, no. 4: 1265.
https://doi.org/10.3390/molecules27041265
APA Style
Wani, T. A., Alanazi, M. M., Alsaif, N. A., Bakheit, A. H., Zargar, S., Alsalami, O. M., & Khan, A. A.
(2022). Interaction Characterization of a Tyrosine Kinase Inhibitor Erlotinib with a Model Transport Protein in the Presence of Quercetin: A Drug–Protein and Drug–Drug Interaction Investigation Using Multi-Spectroscopic and Computational Approaches. Molecules, 27(4), 1265.
https://doi.org/10.3390/molecules27041265